Otsuka Group

Under the banners of "advanced technology," "clean environment," and "superior quality," Otsuka Techno molds and processes various types of resin, from commodity plastics to super engineering plastics.

As a specialist manufacturer of prefilled syringes, the company aims to constantly produce top-quality products with cutting-edge manufacturing equipment, stringent quality control, and continuous product improvements based on medical practice needs.

We will strive to contribute to the health of people around the world through a wide range of innovative and creative products, enteral nutrition formulas (prescription drugs), and iEat, a diet for people who have difficulty chewing, and aim to be a “nutrition care supporter” who can promptly provide more meaningful products and information.

The company contributes to urinary care in the super-aging society by developing devices which can visually indicate the urinary output in the bladder using ultrasound technology and by providing unique solutions.

Suzhou Otsuka Pharmaceutical was established in February 2007 in Suzhou, a major center for Japanese corporations in China. Suzhou Industrial Park, where the company’s factory is located, has rich sources of water and is well known for its beautiful natural environment and favorable climate. Utilizing Japanese technology and equipment, a base of highly skilled and experienced employees manufacture high-quality antibiotics kits.

In 2013, Otsuka Pharmaceutical Factory made capital participation in a newly established IV business company with the aim of entering the IV sector in the promising Indian medical products market. In March 2017, the company name changed to Otsuka Pharmaceutical India Private Limited. Great efforts are being put into the creation of a fusion between respect for Indian culture and the Otsuka ethos, where mutual understanding with local staff is fostered and we all grow together.

Established in 1973 and a member of the Otsuka Group since 1995, PT Widatra Bhakti manufactures and distributes IV products in Indonesia. The company began exporting products to all parts of Asia in 2006, and construction of a new factory was completed in 2013 in anticipation of future market growth. The company has the top share of the Indonesian IV market.

Otsuka Pharmaceutical Vietnam JSC, originally established in 2003 as a joint venture, has its headquarters/factory in Dong Nai province in southern Vietnam, with offices in Ho Chi Minh and Hanoi. The company manufactures and sells IV solutions in plastic bottles and sells them domestically and internationally, and also imports and sells nutritional infusions and medical foods in Vietnam. The company works to contribute to the health and medical development of people not only in Vietnam but also in Southeast Asia.

Egypt Otsuka Pharmaceutical was established as a joint venture in 1993, as the successor to Arab Otsuka Pharmaceutical, which had been in operation since 1977. IV products are manufactured and distributed in Egypt and exported to nearby countries across Africa and the Middle East. We are proactive in expanding production lines and introducing new product lines- at present 30 million IV products are produced every year, with a share of just under 30% of the Egyptian IV market.

In 2014, Egypt Otsuka Pharmaceutical made an Egyptian manufacturing and distribution company of IV solutions a subsidiary with the aim of expanding its manufacturing capacity, and in later years it was renamed “Otsuka Al-Obour Pharmaceutical Egypt S.A.E.” This acquisition strengthened the manufacturing capacity of IV solutions in Egypt and sufficiently meets the increasing demand in the market. Otsuka Al-Obour Pharmaceutical Egypt S.A.E. will supply IV products of high quality to not only Egypt but also the Middle East and Africa.

In 2021, Egypt Otsuka Pharmaceutical Co., S.A.E. jointly invested with a local pharmaceutical company to establish Otsuka Gypto Pharmaceutical Egypt S.A.E. as a new company that sells IV solutions and other ethical drugs. Otsuka Gypto provides information on ethical drugs, including high-quality IV solutions manufactured by Egypt Otsuka Pharmaceutical and the local pharmaceutical company, and will sell the drugs not only in Egypt but also in neighboring countries such as the Middle East and Africa.

Established in 1974 as a joint venture, PT Otsuka Indonesia built a factory in Lawan, East Java, blessed with water resources, and started manufacturing and selling IV products. Starting with manufacturing and selling basic IV solutions, the company currently sells pharmaceuticals in the clinical nutrition field, ethical drugs, and medical devices. Moreover, as a leading company of IV solutions in Indonesia, the company not only develops its business domestically but also exports pharmaceuticals overseas, including to Australia, Singapore, and Sri Lanka.

In 2011, Diatranz Otsuka founded in New Zealand is　working on the development and commercialization of pancreatic islet “DIABECELL®” as a treatment for diabetes. In order to offer new treatment options to patients with diabetes, Diatranz Otsuka aims to commercialize DIABECELL as soon as possible. In addition, to promote the spread of xenotransplantation, we support the establishment of the safety and effectiveness of xenotransplantation.